CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-20 | Sinha Vikas See Remarks | Sale | −1,449 | $9.36 | $14K | 1,036,775 |
| 2022-10-20 | Atillasoy Ercem See Remarks | Sale | −1,527 | $8.48 | $13K | 131,372 |
| 2022-10-19 | Sinha Vikas See Remarks | Sale | −1,449 | $9.36 | $14K | 1,036,775 |
| 2022-10-19 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,070 | $9.36 | $10K | 399,800 |
| 2022-10-19 | Hagen Brett R Chief Accounting Officer | Sale | −345 | $9.36 | $3K | 113,233 |
| 2022-10-19 | Miller Edward General Counsel | Sale | −553 | $9.36 | $5K | 249,377 |
| 2022-10-19 | Atillasoy Ercem See Remarks | Sale | −568 | $9.36 | $5K | 132,899 |
| 2022-10-19 | Hallal David Director | Sale | −600,000 | $8.45 | $5.1M | 138,153 |
| 2022-09-29 | Hallal David Director | Sale | −400,000 | $7.35 | $2.9M | 720,965 |
| 2022-09-02 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −493 | $7.89 | $4K | 400,870 |
| 2022-08-18 | Brainard Diana Chief Executive Officer | Sale | −4,564 | $7.76 | $35K | 637,548 |
| 2022-08-16 | Leen Ann M. Chief Scientific Officer | Grant or award | +15,000 | 43,000 | ||
| 2022-08-16 | Sinha Vikas See Remarks | Grant or award | +100,000 | 1,038,224 | ||
| 2022-08-16 | Miller Edward General Counsel | Grant or award | +15,000 | 249,930 | ||
| 2022-08-16 | Brainard Diana Chief Executive Officer | Grant or award | +100,000 | 642,112 | ||
| 2022-08-16 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −15,590 | $8.30 | $129K | 386,363 |
| 2022-08-16 | VAN BEEK JEROEN B Chief Commercial Officer | Grant or award | +15,000 | 401,363 | ||
| 2022-08-16 | Hagen Brett R Chief Accounting Officer | Grant or award | +20,000 | 113,578 | ||
| 2022-07-28 | Sinha Vikas See Remarks | Grant or award | +3,253,796 | $4.61 | $15.0M | 16,674,766 |
| 2022-07-28 | Hallal David Director | Grant or award | +3,253,796 | $4.61 | $15.0M | 16,674,766 |
Page 12 of 13 · 259 trades